Frontlight ResearchEarly access
Metastatic breast cancer trials in Italy
14 of 70 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTo Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- Where
- Prato
- People
- 150
- Run by
- Fondazione Sandro Pitigliani
See details and how to joinNCT04660435 - No phaseTaking peopleEORTC Metastatic Breast Cancer Module Development
- Where
- Naples, Padova
- Age
- 18 years and over
- People
- 568 worldwide
- Run by
- University of Leeds
See details and how to joinNCT07806266 - No phaseActive, not recruitingDESTINY Breast Respond HER2-(Ultra)Low Europe
- Where
- Alessandria, Chieti, Città di Castello, Empoli, Lecce, Lecco, Legnago, Legnano, Meldola, Modena, Monza, Naples, Novara, Padova, Palermo, Pavia, Pisa, Potenza, Province of Macerata, Reggio Calabria, Reggio Emilia, Roma, Salerno, San Giovanni Rotondo, Sassari, Taormina, Torino, Treviso, Udine, Varese
- Age
- 18 years and over
- People
- 2,295 worldwide
- Run by
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
See details and how to joinNCT05945732 - No phaseTaking peopleEmotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
- Where
- Ancona, Aviano, Bagno a Ripoli, Bari, Bergamo, Brescia, Brindisi, Busto Arsizio, Como, Florence, Genova, Messina, Milan, Modena, Naples, Novara, Palermo, Pavia, Pisa, Prato, Rimini, Roma, Rome, Sassari, Verduno, Verona, Vimercate
- Age
- 18 years and over
- People
- 1,000
- Run by
- European Institute of Oncology
See details and how to joinNCT06994377 - No phaseTaking peopleAnalysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
- Where
- Milan
- Age
- 18 years and over
- People
- 30
- Run by
- European Institute of Oncology
See details and how to joinNCT06706557 - No phaseTaking peoplePIK3CA Mutational Status Assessment
- Where
- Milan
- Age
- 18 years and over
- People
- 100
- Run by
- European Institute of Oncology
See details and how to joinNCT06706570 - No phaseTaking peopleIntegrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,
- Where
- Milan
- Age
- 18 years and over
- People
- 80
- Run by
- European Institute of Oncology
See details and how to joinNCT06762483 - No phaseTaking peopleToxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
- Where
- Milan
- Age
- 18 years and over
- People
- 84
- Run by
- European Institute of Oncology
See details and how to joinNCT07049133 - No phaseTaking peopleRADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
- Where
- Milan
- People
- 500
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT07030569 - No phaseTaking peopleConcomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
- Where
- Rome
- Age
- 18 years and over
- People
- 300
- Run by
- Fondazione Policlinico Universitario Campus Bio-Medico
See details and how to joinNCT07021911 - No phaseTaking peopleWhole Body MRI in Oncology
- Where
- Bologna, Meldola, Milan
- Age
- 18 years and over
- People
- 1,000
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06895291 - No phaseTaking peoplePredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Where
- Aviano, Brescia, Catania, Como, Cremona, Florence, Genova, Meldola, Milan, Mirano, Modena, Naples, Novara, Padova, Pavia, Roma, Rozzano
- Age
- 18 years and over
- People
- 3,500
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06805812 - No phaseTaking peopleEvaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
- Where
- Bologna
- Age
- 18 years and over
- People
- 100
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06800612 - No phaseTaking peopleIncreasing Oral Medication Adherence for Metastatic Breast Cancer Patients
- Where
- Milan
- Age
- 18 years and over
- People
- 104
- Run by
- European Institute of Oncology
See details and how to joinNCT06726889